Cardiovascular Disease Prevalence and Related Outcomes in Nigeria: A Critical Review of Evidence, Measurement Gaps and Care Outcomes

Background: Nigeria is the most populous country in Africa and is passing through an epidemiological transition in which cardiovascular disease is assuming a larger share of adult morbidity, disability and premature death. Estimates of that burden nevertheless vary widely, and their reliability is rarely examined alongside the outcomes that matter to patients and health systems. Purpose and Scope: This critical narrative review appraises evidence on the prevalence, incidence and related outcomes of adult cardiovascular disease in Nigeria, covering hypertension, stroke, heart failure and cardiomyopathies, rheumatic and other valvular disease, atrial fibrillation, coronary heart disease, the principal cardiometabolic risk factors, and mortality, economic and health-system outcomes. Methods: Peer-reviewed literature and institutional reports were identified through structured searches of international and African bibliographic sources, supplemented by citation tracking. Studies were appraised qualitatively for sampling frame, case ascertainment, outcome completeness and analytical transparency, and the findings were synthesised thematically. Principal Findings: Hypertension is the dominant and best-documented condition, affecting roughly one in three adults, with a narrowing urban–rural gradient and very low population-level control. It underlies most stroke, heart failure and sudden cardiac death in Nigerian series. Stroke carries high early case fatality, and heart failure affects relatively young adults with predominantly hypertensive aetiology. Peripartum cardiomyopathy shows a striking concentration in the North-West. Coronary heart disease appears to be rising, but its burden remains uncertain because diagnostic capacity is limited. Much of the evidence is hospital-based, regionally clustered and methodologically heterogeneous, and population-level mortality data remain scarce. Unresolved Questions: True incidence trends, cause-specific mortality, long-term outcomes after stroke and heart failure, and the scalability of primary-care hypertension programmes remain poorly characterised. Implications: Priorities include a standardised national cardiovascular surveillance platform linked to civil registration and verbal autopsy, population-based stroke and heart failure registries, financial protection for chronic cardiovascular care, and sustained investment in primary-care hypertension control. Conclusion: The evidence supports treating hypertension control as the central lever for reducing cardiovascular harm in Nigeria, while emphasising that current burden estimates rest on fragile and uneven data.

Authors

Institutions

Publication Details

Journal
Journal of Advances in Medical and Pharmaceutical Sciences
Published
2026-11-17
DOI
https://doi.org/10.9734/jamps/2026/v28i11912
Primary Topic
Global Health and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiovascular Disease Prevalence and Related Outcomes in Nigeria: A Critical Review of Evidence, Measurement Gaps and Care Outcomes

Waleola Bukola Ige, Taiwo Folake OJO, Mary Ayodeji Olofin-Samuel, Temitope Grace Ayo-Oluwaseyi et al.
1 links
Journal of Advances in Medical and Pharmaceutical Sciences
Global Health and Epidemiology
article

Cardiovascular Disease Prevalence and Related Outcomes in Nigeria: A Critical Review of Evidence, Measurement Gaps and Care Outcomes

Waleola Bukola Ige, Taiwo Folake OJO, Mary Ayodeji Olofin-Samuel, Temitope Grace Ayo-Oluwaseyi, Anuoluwa Deborah Odiru, Gentry Oluwabukola Ayo, Deborah Adebimpe Awolumate
article en

Abstract

Background: Nigeria is the most populous country in Africa and is passing through an epidemiological transition in which cardiovascular disease is assuming a larger share of adult morbidity, disability and premature death. Estimates of that burden nevertheless vary widely, and their reliability is rarely examined alongside the outcomes that matter to patients and health systems. Purpose and Scope: This critical narrative review appraises evidence on the prevalence, incidence and related outcomes of adult cardiovascular disease in Nigeria, covering hypertension, stroke, heart failure and cardiomyopathies, rheumatic and other valvular disease, atrial fibrillation, coronary heart disease, the principal cardiometabolic risk factors, and mortality, economic and health-system outcomes. Methods: Peer-reviewed literature and institutional reports were identified through structured searches of international and African bibliographic sources, supplemented by citation tracking. Studies were appraised qualitatively for sampling frame, case ascertainment, outcome completeness and analytical transparency, and the findings were synthesised thematically. Principal Findings: Hypertension is the dominant and best-documented condition, affecting roughly one in three adults, with a narrowing urban–rural gradient and very low population-level control. It underlies most stroke, heart failure and sudden cardiac death in Nigerian series. Stroke carries high early case fatality, and heart failure affects relatively young adults with predominantly hypertensive aetiology. Peripartum cardiomyopathy shows a striking concentration in the North-West. Coronary heart disease appears to be rising, but its burden remains uncertain because diagnostic capacity is limited. Much of the evidence is hospital-based, regionally clustered and methodologically heterogeneous, and population-level mortality data remain scarce. Unresolved Questions: True incidence trends, cause-specific mortality, long-term outcomes after stroke and heart failure, and the scalability of primary-care hypertension programmes remain poorly characterised. Implications: Priorities include a standardised national cardiovascular surveillance platform linked to civil registration and verbal autopsy, population-based stroke and heart failure registries, financial protection for chronic cardiovascular care, and sustained investment in primary-care hypertension control. Conclusion: The evidence supports treating hypertension control as the central lever for reducing cardiovascular harm in Nigeria, while emphasising that current burden estimates rest on fragile and uneven data.

Journal of Advances in Medical and Pharmaceutical SciencesVol. 28(11)
Ekiti State University (NG), Afe Babalola University (NG), Federal University Oye Ekiti (NG)
Good health and well-being
Global Health and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon